Stocks to sell

Whether or not you’re bullish on artificial intelligence (AI), it’s had an undeniable impact upon marketing and branding strategies of renowned tech companies. AI is forcing tech into the machine learning (ML) era. Yet, not every tech company is truly a contributor to the AI revolution. These companies result in overvalued AI stocks and can

Technology sector stocks are the driving force behind today’s bull market. The S&P 500 has been up 45% since the beginning of 2023 and 26% higher in the last 12 months. The tech sector is up 46% in the past year and has tripled in value in the previous five years. The Magnificent Seven stocks

There’s definitely a science to picking beaten-down gems in the stock market. If you get it wrong, you could lose a lot of money. Ginkgo Bioworks (NYSE:DNA) is certainly an interesting company and Ginkgo Bioworks stock is beaten down, but the risk-to-reward profile just isn’t favorable right now. Ginkgo Bioworks, which specializes in cell programming

Spotting read flags early can play a crucial role in protecting your portfolio. Today, I’m going to look into three stocks to sell. The stocks include two mortgage REITs and a data center REIT. Some investors may focus too heavily on a stock’s dividend yield. I urge investors to take a look at troubling signs

Last month, Nikola (NASDAQ:NKLA) shares cratered in price, following the announcement and completion of a 1-for-30 reverse stock split. However, so far this month, Nikola stock has been bolting out of the stock market junkyard. Since July 2, this fallen angel of an EV stock has bounced back from its lows, and has climbed back

AI chip stocks have been zooming higher in recent days. Intel (NASDAQ:INTC) shares are no exception. Yet while a quick move back to the mid-$30s per share for Intel stock may look like a sign to buy before it’s too late, consider the following before putting in a “buy” order. The market may keep bidding

Biotechnology stocks can be thrilling and profitable when you’re on the winning side of a trade. G1 Therapeutics’ (NASDAQ:GTHX) started hot, but then the bottom fell out after an unfortunate announcement. With that in mind, G1 Therapeutics stock is just too risky to recommend right now. Based in North Carolina, G1 Therapeutics specializes in oncology

While the term “Internet of Things” (IoT) may not sound very technical, it refers to a technological sector focused on interconnectivity between electronic devices and the data they generate. Examples of this include smart home appliances, like remote-controlled lighting, smart fridges and even devices like Amazon’s (NASDAQ:AMZN) Alexa. The purpose of devices like these is

Following the French election results, French stocks have seen dramatic shifts in response to the electoral outcomes. Leading up to the first round, French stocks underwent notable volatility as fears mounted over potentially expansive spending under either a far-right or far-left majority, posing risks to the country’s already fragile fiscal stability. In any case, the

Cathie Wood’s portfolio hasn’t performed well in recent years. Ever since the post-pandemic boom ended, her performance has trailed the broader market. This has caused many investors to start taking a contrarian view of her bets. For example, the Tuttle Capital Short Innovation ETF (NASDAQ:SARK) exists, which is up almost 9% year-to-date during a market

From an enterprise perspective, 5G has been a game changer for high-speed data transfer and low-latency connections. Yet, many consumers report relatively unimpressive experiences with the 5th generation of telecommunication networks. Part of this might be due to the more niche benefits 5G provides over 4G and the fact that around 40% of users across

Short selling is like all investing in that it is part art, part science. Investors who pick short sale stocks use fundamental and technical indicators to inform their belief that a given share will decline in price. They also leverage instinct and a feeling that they’re correct. It’s exactly the same as buy and hold

Many penny stocks have potential to break through the “penny stock ceiling” of $5 per share. Conversely, a great deal of stocks are trading above “penny stock territory,” which could be best described as doomed penny stocks. While seemingly cheap today, these hopeless equities stand a strong chance of becoming even cheaper, due to worsening

The S&P 500 has gained over 17% year-to-date (YTD), and it is turning out to be another great year for investors. However, amidst all the good news, some huge disappointments have surfaced for investors. These three stocks have been disastrous for their holders. Their value has fallen by double digits, and they show no signs

About the only positive for the Democrats when it comes to the June 27 debate between President Joe Biden and Republican candidate and former President Donald Trump is the catastrophe happened relatively early. Other than that, it was a huge victory for conservatives, which should then bode well for Trump Media & Technology Group (NASDAQ:DJT).

Investing in individual stocks is not for the faint of heart, and can result in substantial losses for prospective investors. As Q3 2024 kicks off, now is a great time to consider the top toxic stocks to sell.  While some stocks promise sustainable returns, others pose significant risks that can erode your investment capital. The

In today’s adverse market conditions, understanding when to sell stocks is as crucial as knowing when to invest. The focus here is on three companies that should be considered for potential divestment. Each of these companies faces unique challenges that signal potential trouble for investors. Indeed, these companies have fundamental weaknesses. For instance, despite promising

Tesla (NASDAQ:TSLA) stock might be rallying, but electric vehicle maker still looks like a bad long-term investment idea. A fuse has been lit underneath Tesla stock. Since July 1, the company’s share price has risen 27%, erasing its previous losses on the year. Trading above $250 per share, TSLA stock appears to have momentum behind

The outlook of many healthcare stocks is quite positive at this point. That’s partly because many large investors have shunned the sector, since they believe that it is destined to produce horrible returns as long as interest rates remain elevated. As a result, many firms in the space have very attractive valuations. Moreover, even some

The world of gaming has never been so full of opportunity and uncertainty. For an industry that’s expected to grow to a market value of $312 billion by 2027, many of its biggest players are still divided over how this growth will manifest itself.  Although Microsoft’s (NASDAQ:MSFT) 2022 acquisition of leading gaming firm Activision Blizzard